H. B. Fuller (NYSE:FUL) Updates FY 2026 Earnings Guidance

H. B. Fuller (NYSE:FUL) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 4.350-4.700 for the period. The company issued revenue guidance of $3.5 billion-$3.5 billion.

H. B. Fuller Trading Down 2.2%

Shares of NYSE FUL traded down $1.47 during midday trading on Wednesday, hitting $64.83. The stock had a trading volume of 1,074,910 shares, compared to its average volume of 515,964. The company has a fifty day moving average price of $59.39 and a 200 day moving average price of $59.66. The company has a market capitalization of $3.51 billion, a price-to-earnings ratio of 35.04, a PEG ratio of 1.07 and a beta of 1.10. H. B. Fuller has a 1-year low of $47.56 and a 1-year high of $67.05. The company has a quick ratio of 1.18, a current ratio of 1.93 and a debt-to-equity ratio of 1.06.

H. B. Fuller (NYSE:FUL) last issued its quarterly earnings results on Wednesday, January 14th. The specialty chemicals company reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.04. H. B. Fuller had a return on equity of 11.49% and a net margin of 3.28%.H. B. Fuller has set its FY 2026 guidance at 4.350-4.700 EPS. On average, analysts predict that H. B. Fuller will post 4.07 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on FUL shares. Wall Street Zen lowered shares of H. B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, November 24th. Citigroup upgraded H. B. Fuller from a “neutral” rating to a “buy” rating and increased their target price for the stock from $62.00 to $70.00 in a report on Wednesday, October 22nd. UBS Group initiated coverage on shares of H. B. Fuller in a research report on Friday, November 21st. They set a “neutral” rating and a $60.00 price target on the stock. Seaport Res Ptn raised shares of H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 26th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of H. B. Fuller in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, H. B. Fuller presently has a consensus rating of “Moderate Buy” and a consensus target price of $66.20.

Insider Buying and Selling at H. B. Fuller

In related news, VP Nathan D. Weaver sold 7,075 shares of the company’s stock in a transaction that occurred on Thursday, November 13th. The shares were sold at an average price of $58.38, for a total transaction of $413,038.50. Following the completion of the transaction, the vice president directly owned 9,441 shares in the company, valued at $551,165.58. This represents a 42.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John J. Corkrean sold 14,222 shares of the firm’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $60.31, for a total transaction of $857,728.82. Following the completion of the transaction, the chief financial officer owned 54,646 shares of the company’s stock, valued at approximately $3,295,700.26. This trade represents a 20.65% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.99% of the company’s stock.

Institutional Investors Weigh In On H. B. Fuller

Several large investors have recently modified their holdings of the stock. BNP Paribas Financial Markets grew its stake in H. B. Fuller by 38.7% during the second quarter. BNP Paribas Financial Markets now owns 5,620 shares of the specialty chemicals company’s stock valued at $338,000 after acquiring an additional 1,568 shares in the last quarter. Brevan Howard Capital Management LP grew its holdings in H. B. Fuller by 96.8% during the 2nd quarter. Brevan Howard Capital Management LP now owns 12,921 shares of the specialty chemicals company’s stock worth $777,000 after acquiring an additional 6,356 shares in the last quarter. Quantinno Capital Management LP raised its position in shares of H. B. Fuller by 137.3% in the 2nd quarter. Quantinno Capital Management LP now owns 9,929 shares of the specialty chemicals company’s stock worth $597,000 after acquiring an additional 5,745 shares in the last quarter. Cerity Partners LLC increased its position in shares of H. B. Fuller by 2.3% during the second quarter. Cerity Partners LLC now owns 11,499 shares of the specialty chemicals company’s stock worth $692,000 after purchasing an additional 261 shares in the last quarter. Finally, Baird Financial Group Inc. grew its position in H. B. Fuller by 19.6% during the 2nd quarter. Baird Financial Group Inc. now owns 7,518 shares of the specialty chemicals company’s stock worth $452,000 after purchasing an additional 1,232 shares during the last quarter. Hedge funds and other institutional investors own 95.93% of the company’s stock.

About H. B. Fuller

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.